Our research showed that PSMC2 was markedly upregulated in patient HCC tissues compared with adjacent non-cancerous tissues, and its upregulation was positively correlated with worse survival outcomes in HCC patients. This evidence concerns the gene PSMC2 and hepatocellular carcinoma.